TY - JOUR
T1 - Dietary Antioxidants and Longitudinal Changes in Lower Urinary Tract Symptoms in Elderly Men
T2 - The Osteoporotic Fractures in Men Study
AU - for the Osteoporotic Fractures in Men Study Group
AU - Holton, Kathleen F.
AU - Marshall, Lynn M.
AU - Shannon, Jackilen
AU - Lapidus, Jodi A.
AU - Shikany, James M.
AU - Bauer, Douglas C.
AU - Barrett-Connor, Elizabeth
AU - Parsons, J. Kellogg
N1 - Funding Information:
Funding/Support and role of the sponsor: This research was supported by Grant R21 DK083675 from the National Institute for Diabetes, Digestive and Kidney Diseases. The Osteoporotic Fractures in Men (MrOS) Study is supported by National Institutes of Health (NIH) funding. The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), the National Institute on Aging (NIA), the National Center for Research Resources (NCRR), and the NIH Roadmap for Medical Research provided support under grant numbers U01 AR45580, U01 AR45614, U01 AR45632, U01 AR45647, U01 AR45654, U01 AR45583, U01 AG18197, U01 AG027810, and UL1 TR000128. The sponsors played a role in data collection, management, and analysis.
Publisher Copyright:
© 2015 European Association of Urology
PY - 2016/8/1
Y1 - 2016/8/1
N2 - Background Antioxidants can potentially alter the progression of lower urinary tract symptoms (LUTS) through anti-inflammatory mechanisms. Objective To determine if dietary antioxidants are associated with reduced likelihood of LUTS progression or increased likelihood of LUTS remission in untreated elderly men. Design, setting, and participants A prospective cohort study of 1670 US men aged 65–100 yr. Outcome measurements and statistical analysis Baseline variables included the American Urological Association Symptom Index, dietary intake assessed via a 69-item Block food frequency questionnaire (FFQ), demographics, lifestyle characteristics, quality of life (SF-12), and medication use. LUTS was assessed at four time points over a mean ± standard deviation period of 6.9 ± 0.4 yr. Group-based trajectory modeling was performed for men without prostate cancer who did not undergo LUTS treatment with medication or surgery during follow-up (n = 1670). Analyses were stratified by LUTS symptoms at baseline. For men with mild baseline LUTS, we examined the likelihood of LUTS progression relative to LUTS stability. For men with moderate baseline LUTS, we analyzed the likelihood of both LUTS progression relative to LUTS stability and LUTS remission relative to progression. Odds ratios and 95% confidence intervals were estimated for quartiles of daily antioxidant intake using multivariable logistic regression. Results and limitations None of the dietary antioxidants (vitamin C, vitamin E, β-carotene, α-carotene, β-cryptoxanthin, lycopene, lutein/zeaxanthin) was associated with a lower probability of LUTS progression or LUTS remission. The study was limited by use of the brief Block FFQ, which contains only 69 food items and may have biased results toward the null hypothesis because of nondifferential misclassification. Conclusions In this large cohort of US men, there were no significant associations between multiple dietary antioxidants and LUTS progression or remission over 7 yr. Patient summary In a large cohort of elderly men, there were no significant longitudinal associations between multiple dietary antioxidants and lower urinary tract symptoms (LUTS). Our data suggest that dietary antioxidant consumption may not influence the natural history of LUTS in older men.
AB - Background Antioxidants can potentially alter the progression of lower urinary tract symptoms (LUTS) through anti-inflammatory mechanisms. Objective To determine if dietary antioxidants are associated with reduced likelihood of LUTS progression or increased likelihood of LUTS remission in untreated elderly men. Design, setting, and participants A prospective cohort study of 1670 US men aged 65–100 yr. Outcome measurements and statistical analysis Baseline variables included the American Urological Association Symptom Index, dietary intake assessed via a 69-item Block food frequency questionnaire (FFQ), demographics, lifestyle characteristics, quality of life (SF-12), and medication use. LUTS was assessed at four time points over a mean ± standard deviation period of 6.9 ± 0.4 yr. Group-based trajectory modeling was performed for men without prostate cancer who did not undergo LUTS treatment with medication or surgery during follow-up (n = 1670). Analyses were stratified by LUTS symptoms at baseline. For men with mild baseline LUTS, we examined the likelihood of LUTS progression relative to LUTS stability. For men with moderate baseline LUTS, we analyzed the likelihood of both LUTS progression relative to LUTS stability and LUTS remission relative to progression. Odds ratios and 95% confidence intervals were estimated for quartiles of daily antioxidant intake using multivariable logistic regression. Results and limitations None of the dietary antioxidants (vitamin C, vitamin E, β-carotene, α-carotene, β-cryptoxanthin, lycopene, lutein/zeaxanthin) was associated with a lower probability of LUTS progression or LUTS remission. The study was limited by use of the brief Block FFQ, which contains only 69 food items and may have biased results toward the null hypothesis because of nondifferential misclassification. Conclusions In this large cohort of US men, there were no significant associations between multiple dietary antioxidants and LUTS progression or remission over 7 yr. Patient summary In a large cohort of elderly men, there were no significant longitudinal associations between multiple dietary antioxidants and lower urinary tract symptoms (LUTS). Our data suggest that dietary antioxidant consumption may not influence the natural history of LUTS in older men.
KW - Benign prostatic hyperplasia
KW - Bladder outlet obstruction
KW - Elderly
KW - Epidemiology
KW - Fall
KW - Fracture
KW - Lower urinary tract symptoms
KW - Risk factor
UR - http://www.scopus.com/inward/record.url?scp=84994731755&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84994731755&partnerID=8YFLogxK
U2 - 10.1016/j.euf.2015.09.006
DO - 10.1016/j.euf.2015.09.006
M3 - Article
AN - SCOPUS:84994731755
SN - 2405-4569
VL - 2
SP - 310
EP - 318
JO - European Urology Focus
JF - European Urology Focus
IS - 3
ER -